Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention

Clinical trial NCT07536802 · RECRUITING

Trial details

NCT number: NCT07536802
Sponsor: National Institute of Cardiovascular Diseases, Pakistan
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

ST-Segment Elevation Myocardial Infarction (STEMI)No-Reflow Phenomenon Coronary Slow Flow Acute Myocardial Infarction

Start date: 2025-06-01
Primary completion: 2026-05-30
Enrollment: 1148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.